News
FDA Appoints Biotech Executive as Top Drug Regulator
Digest more
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...
Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this ...
A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...
WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...
The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...
With abortion pills by mail and a new amendment decriminalizing women who end their own pregnancies, can evangelicals ...
Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...
The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback